<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-108811</identifier>
<setSpec>1134-248X</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">High-dose subcutaneous oxycodone: case report</dc:title>
<dc:description xml:lang="en">We report the case of a 57 year-old patient with a metastatic anal epidermoid cancer. She progressively developed severe somatic pain in her buttocks, with breakthrough pain crises 8/10 located in the sacrum, which were well managed with oral oxycodone. Despite initial impressions, the pain crises were found to be partially related to radiotherapy side effects. She subsequently had intractable vomiting related to metastases in the cerebellum which was controlled with parenteral antihistamines and olanzapine. For this same reason, a switch in the route of administration to continuous subcutaneous infusion of oxycodone was performed. Parenteral oxycodone was maintained for 43 days at a dose of 300 mg/day, and was combined with several drugs (haloperidol, metoclopramide, hyoscine hydrobromide, midazolam, hyoscine butylbromide). The infusion was found to be quite effective in dealing with the symptoms, and no problems of incompatibility were detected with the co-administration of the various drugs. A skin reaction was detected one week after starting the infusion, which was easily managed by rotation of the injection site (AU)</dc:description>
<dc:creator>Prieto Vicente , Pilar</dc:creator>
<dc:creator>Martínez, Julia Romero</dc:creator>
<dc:creator>Suárez González, José Ramón</dc:creator>
<dc:creator>Núñez Olarte, Juan Manuel</dc:creator>
<dc:creator>Viloria Jiménez, Aurora</dc:creator>
<dc:creator>Sánchez Sobrino, Magdalena</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Presentamos el caso de una paciente de 57 años de edad, que presentaba un cáncer epidermoide de canal anal metastásico. En su evolución presentó un intenso dolor glúteo somático con crisis de dolor irruptivo sacras 8/10 controladas con oxicodona oral. A pesar de la impresión inicial, la etiología de las crisis resultó ser secundaria, en parte, a secuelas de tratamiento radioterápico previo. Posteriormente, la aparición de metástasis cerebelosas condicionó la presencia de vómitos de difícil manejo, finalmente controlados con antihistamínicos y olanzapina parenterales. Por este mismo motivo, se procedió a la rotación de la vía de administración a oxicodona en perfusión subcutánea continua. La oxicodona parenteral se mantuvo durante 43 días, a dosis de 300 mg/día, y en la perfusión se combinaron diversos fármacos (haloperidol, metoclopramida, escopolamina, midazolam, butilbromuro de escopolamina). Esta perfusión resultó claramente eficaz para el control de la sintomatología, sin que se evidenciaran problemas de incompatibilidad en la combinación de fármacos. Se observó una discreta reacción cutánea a partir de la semana de infusión, fácilmente controlable rotando el punto de inserción de la palomilla (AU)</dc:description>
<dc:source>Med. paliat;18(3): 87-91, jul.-sept. 2011. ilus</dc:source>
<dc:identifier>ibc-108811</dc:identifier>
<dc:title xml:lang="es">Oxicodona en altas dosis por vía subcutánea: a propósito de un caso</dc:title>
<dc:subject>^d10279^s22000</dc:subject>
<dc:subject>^d7453</dc:subject>
<dc:subject>^d4400</dc:subject>
<dc:subject>^d21012</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d1011^s22012</dc:subject>
<dc:subject>^d9062</dc:subject>
<dc:subject>^d54692^s22045</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:type>article</dc:type>
<dc:date>201109</dc:date>
</metadata>
</record>
</ibecs-document>
